Theradaptive Announces First Patient Treated in RESTORE Dental Study
Theradaptive, Inc. has treated the first patient in its RESTORE International Phase I/II Feasibility Study. The study will evaluate the safety and performance of OsteoAdapt™ DE in promoting bone growth for dental reconstruction. Advancing Bone Regeneration in Dentistry The procedure was performed by Dr. Gal Avishai at Rabin Medical Center in Israel. Dr. Avishai noted […]
Theradaptive Secures Landmark Funding to Propel Human Clinical Trials in Stem Cell Research
In a groundbreaking development for stem cell research and regenerative medicine, Theradaptive has secured significant funding from the Maryland Stem Cell Research Fund (MSCRF). This crucial financial boost will support the advancement of their innovative human clinical trials, marking a significant milestone in the field of biotechnology. Theradaptive, a pioneering biopharmaceutical company, is renowned for […]